[go: up one dir, main page]

AU2013260709B9 - Genetic products differentially expressed in tumors and the use thereof - Google Patents

Genetic products differentially expressed in tumors and the use thereof

Info

Publication number
AU2013260709B9
AU2013260709B9 AU2013260709A AU2013260709A AU2013260709B9 AU 2013260709 B9 AU2013260709 B9 AU 2013260709B9 AU 2013260709 A AU2013260709 A AU 2013260709A AU 2013260709 A AU2013260709 A AU 2013260709A AU 2013260709 B9 AU2013260709 B9 AU 2013260709B9
Authority
AU
Australia
Prior art keywords
tumors
differentially expressed
genetic products
products differentially
genetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2013260709A
Other versions
AU2013260709A1 (en
AU2013260709C1 (en
AU2013260709B2 (en
Inventor
Stefan Fritz
Harald-Gerhard Geppert
Michael Koslowski
Ugur Sahin
Özlem TÜRECI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011256897A external-priority patent/AU2011256897B2/en
Priority to AU2013260709A priority Critical patent/AU2013260709C1/en
Priority claimed from AU2013260709A external-priority patent/AU2013260709C1/en
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of AU2013260709A1 publication Critical patent/AU2013260709A1/en
Application granted granted Critical
Publication of AU2013260709B2 publication Critical patent/AU2013260709B2/en
Publication of AU2013260709B9 publication Critical patent/AU2013260709B9/en
Priority to AU2016203425A priority patent/AU2016203425C1/en
Publication of AU2013260709C1 publication Critical patent/AU2013260709C1/en
Assigned to ASTELLAS PHARMA INC. reassignment ASTELLAS PHARMA INC. Request for Assignment Assignors: GANYMED PHARMACEUTICALS AG
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2013260709A 2004-05-18 2013-11-21 Genetic products differentially expressed in tumors and the use thereof Expired AU2013260709C1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2013260709A AU2013260709C1 (en) 2004-05-18 2013-11-21 Genetic products differentially expressed in tumors and the use thereof
AU2016203425A AU2016203425C1 (en) 2004-05-18 2016-05-25 Genetic products differentially expressed in tumors and the use thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004024617.3 2004-05-18
AU2011256897A AU2011256897B2 (en) 2004-05-18 2011-12-16 Genetic products differentially expressed in tumors and the use thereof
AU2013260709A AU2013260709C1 (en) 2004-05-18 2013-11-21 Genetic products differentially expressed in tumors and the use thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2011256897A Division AU2011256897B2 (en) 2004-05-18 2011-12-16 Genetic products differentially expressed in tumors and the use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016203425A Division AU2016203425C1 (en) 2004-05-18 2016-05-25 Genetic products differentially expressed in tumors and the use thereof

Publications (4)

Publication Number Publication Date
AU2013260709A1 AU2013260709A1 (en) 2013-12-12
AU2013260709B2 AU2013260709B2 (en) 2016-04-28
AU2013260709B9 true AU2013260709B9 (en) 2016-05-12
AU2013260709C1 AU2013260709C1 (en) 2016-09-08

Family

ID=55861957

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013260709A Expired AU2013260709C1 (en) 2004-05-18 2013-11-21 Genetic products differentially expressed in tumors and the use thereof

Country Status (1)

Country Link
AU (1) AU2013260709C1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1251863A4 (en) * 2000-01-31 2005-03-02 Human Genome Sciences Inc 22 human secreted proteins

Similar Documents

Publication Publication Date Title
IL231294A0 (en) Genetic products differentially expressed in tumors and the use thereof
AU2005259395B2 (en) Breadmaking methods and products
SI1749027T1 (en) Gene products expressed differentially in tumors and use thereof
ZA200706254B (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
IL163900A0 (en) Genetic products differentially expressed in tumors and use thereof
AU2003220387A1 (en) Gene amplification in cancer
AU2003217421A1 (en) Prostate specific genes and the use thereof in design or therapeutics
AU2013260709B9 (en) Genetic products differentially expressed in tumors and the use thereof
AU2013260709A1 (en) Genetic products differentially expressed in tumors and the use thereof
AU2003226557A1 (en) Differentially expressed genes in conjunctivial pterygium
EP1766082B8 (en) Cog47 protein and s100beta gene polymorphism
AU2003290461A1 (en) Polymorhisms in the dihydropyrimidase gene
AU2004906042A0 (en) The Medi-PDA and the Medi-Comp
AU2004905277A0 (en) DNA delivery and expression system
HK1111355A (en) Apogossypolone and the uses thereof
HK1100035A (en) 2-methylpropanamides and their use as pharmaceuticals
AU2004900719A0 (en) Sperm-Active Preparations and Uses Thereof
AU2004901544A0 (en) Cancer and testis proteins and uses thereof
GB0421914D0 (en) Drug metabolising enzyme in cancer
AU2005904730A0 (en) DNA delivery and expression system
HK1087104A (en) Quinoline derivates and their use in therapy
HK1108033A (en) Distributor-based transaction processing arrangement and approach
HK1103350A (en) Hai-1 and hai-2 in cancer therapy
HK1108360A (en) Drug delivery product and methods
HK1111163A (en) Dihydroxyanthraquinones and their use